RE:RE:RE:RE:RE:New FDA Proposed Guidance on AAThanks for clarifying the Vicinium rejection, Enrique. That's the one that had me worried in terms of FDA trying to appear neutral by asking TLT to do the same. But if it was "only" 15%, makes sense. TLT is already above Keytruda and Adstiladrin with fewer treatments and better safety like you said. There's hope. The clock seems to tick louder these days. Must be the waiting.